Imaging of Prostate Cancer Using Urokinase-Type Plasminogen Activator Receptor PET.


Urokinase-type plasminogen activator receptor (uPAR) overexpression is an important biomarker for aggressiveness in cancer including prostate cancer (PC) and provides independent clinical information in addition to prostate-specific antigen and Gleason score. This article focuses on uPAR PET as a new diagnostic and prognostic imaging biomarker in PC. Many… (More)
DOI: 10.1016/j.cpet.2016.12.005


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics